SABS
SAB Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
6.46 / 10
Netural
The stock demonstrates favorable technical configuration with an overall technical score of 6.46/10. Bullish indicators include Long Upper Shadow and Marubozu White, while no significant factors show concerning signals. The technical outlook appears cautiously optimistic based on current momentum patterns.
Analysis Checks(2/2)
Long Upper Shadow
Score6.22/10
Win Rate51.47%
Hist. Signals68
Avg Return2.21%
Score6.22/10
Win Rate51.47%
Hist. Signals68
Avg Return2.21%
Marubozu White
Score6.69/10
Win Rate58.33%
Hist. Signals24
Avg Return1.27%
Score6.69/10
Win Rate58.33%
Hist. Signals24
Avg Return1.27%
Long Upper Shadow
Score6.22/10
Win Rate51.47%
Hist. Signals68
Avg Return2.21%
Score6.22/10
Win Rate51.47%
Hist. Signals68
Avg Return2.21%
Marubozu White
Score6.69/10
Win Rate58.33%
Hist. Signals24
Avg Return1.27%
Score6.69/10
Win Rate58.33%
Hist. Signals24
Avg Return1.27%
Technical Analysis of SABS?
- SABS presents a Netural setup with a Technical Score of 6.46/10. Key technical indicators highlight an RSI of 48.56 and a MACD of -0.01, with the trend anchored by the 50-Day SMA at 4.01. Traders should monitor key support at 3.83 and resistance at 3.92.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
